Cerus Corp chief medical officer sells $90,570 in stock

Published 06/03/2025, 02:26
Cerus Corp chief medical officer sells $90,570 in stock

Benjamin Richard J, the Chief Medical (TASE:BLWV) Officer of Cerus Corp (NASDAQ:CERS), recently executed a series of stock transactions according to a filing with the Securities and Exchange Commission. On March 3 and 4, Richard sold a total of 57,546 shares of Cerus Corp common stock, generating approximately $90,570. The sales were conducted at prices ranging from $1.5485 to $1.577 per share. The company, currently valued at $300 million, has shown revenue growth of 15% over the last twelve months, though InvestingPro data indicates it remains unprofitable.

These transactions were part of a pre-arranged trading plan under Rule 10b5-1, which allows insiders to sell stock at predetermined times to avoid accusations of insider trading. Following these sales, Richard holds 394,373 shares in the company. According to InvestingPro analysis, the stock shows significant price volatility, with a beta of 1.56, while maintaining strong liquidity with a current ratio of 2.39. Get access to 6 more exclusive ProTips and comprehensive analysis in the Pro Research Report, available for over 1,400 US stocks.

In other recent news, Cerus Corporation reported its fourth-quarter 2024 earnings, revealing a stronger financial performance than anticipated. The company achieved an earnings per share (EPS) of -$0.01, surpassing the forecasted -$0.02. Revenue also exceeded expectations, reaching $56.75 million compared to the projected $53.76 million. Cerus’s product revenue for the quarter grew 9% year-over-year, contributing to a 15% increase for the full year, totaling $180.3 million. Additionally, the company achieved positive adjusted EBITDA of $5.7 million for 2024. Despite these positive results, Cerus’s stock experienced a decline post-announcement. In other developments, Cerus plans to expand its international market presence, targeting regions such as EMEA, China, and Brazil. The company anticipates regulatory approval in China and aims to enter the Brazilian market later in the year.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.